Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 11, 2023 | Neurophth Therapeutics | $95.0M Series C | Hubei KTLC, Wuhan, Wuhan Hi-Tech Holding Group, Wuhan Optical Valley Financial Holding Group, Yangtze River-CMB International Industry Fund | Silicon Paradise Asset Management, Yangtze River Industry Fund |
| Nov 23, 2021 | Neurophth Therapeutics | $60.0M Series C | CMG-SDIC Capital, Hongshan Capital Group (Sequoia Capital China) | CMB International |